These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10091946)

  • 1. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
    Malusecka E; Zborek A; Krzyzowska-Gruca S
    Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
    Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
    Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16 and lack of pRB in primary small cell lung cancer.
    Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
    J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RB growth control evasion in lung cancer.
    Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A
    Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population.
    Mathew R; Arora S; Khanna R; Shukla NK; Mathur M; Ralhan R
    J Cancer Res Clin Oncol; 2001 Apr; 127(4):251-7. PubMed ID: 11315260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A study on p16, pRb, cdk4 and cyclinD1 expression in non-small cell lung cancers.
    Lingfei K; Pingzhang Y; Zhengguo L; Jianhua G; Yaowu Z
    Cancer Lett; 1998 Aug; 130(1-2):93-101. PubMed ID: 9751261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of p53, p16(INK4a), pRb and Cyclin D1 expression and human papillomavirus in primary ovarian serous carcinomas.
    Bilyk OO; Pande NT; Buchynska LG
    Exp Oncol; 2011 Sep; 33(3):150-6. PubMed ID: 21956468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
    Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
    J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
    Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
    Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
    Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
    Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
    Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and clinical significance of the G1-S modulators in carcinoma of the extrahepatic bile duct.
    Ito Y; Takeda T; Sakon M; Monden M; Tsujimoto M; Matsuura N
    Anticancer Res; 2000; 20(1A):337-44. PubMed ID: 10769677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
    Semczuk A; Miturski R; Skomra D; Jakowicki JA
    Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered p16INK4 and retinoblastoma protein status in non-small cell lung cancer: potential synergistic effect with altered p53 protein on proliferative activity.
    Kinoshita I; Dosaka-Akita H; Mishina T; Akie K; Nishi M; Hiroumi H; Hommura F; Kawakami Y
    Cancer Res; 1996 Dec; 56(24):5557-62. PubMed ID: 8971152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclin D1 amplification is independent of p16 inactivation in head and neck squamous cell carcinoma.
    Okami K; Reed AL; Cairns P; Koch WM; Westra WH; Wehage S; Jen J; Sidransky D
    Oncogene; 1999 Jun; 18(23):3541-5. PubMed ID: 10376532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.